Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Michelakis

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|June 3, 2005
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertensionM Sean McMurtry, Stephen L Archer, Dario C Altieri, et al.
Cell|July 5, 2014
A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylationGopinath Sutendra, Adam Kinnaird, Peter Dromparis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 15, 2001
Potassium channels regulate tone in rat pulmonary veinsE D Michelakis, E K Weir, X Wu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 8, 2008
A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targetedJayan Nagendran, Vikram Gurtu, David Z Fu, et al.
Circulation|October 22, 2003
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertensionEvangelos D Michelakis, Wayne Tymchak, Michelle Noga, et al.
Advances in Experimental Medicine and Biology|April 13, 2002
Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human modelsE D Michelakis, J R Dyck, M S McMurtry, et al.
Cell Metabolism|October 7, 2014
Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humansRoxane Paulin, Peter Dromparis, Gopinath Sutendra, et al.
Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.
Circulation|September 16, 2009
Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axisSébastien Bonnet, Roxane Paulin, Gopinath Sutendra, et al.
Circulation Research|June 26, 2004
Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cellsStephen L Archer, Xi-Chen Wu, Bernard Thébaud, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|June 3, 2005
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertensionM Sean McMurtry, Stephen L Archer, Dario C Altieri, et al.
Cell|July 5, 2014
A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylationGopinath Sutendra, Adam Kinnaird, Peter Dromparis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 15, 2001
Potassium channels regulate tone in rat pulmonary veinsE D Michelakis, E K Weir, X Wu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 8, 2008
A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targetedJayan Nagendran, Vikram Gurtu, David Z Fu, et al.
Circulation|October 22, 2003
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertensionEvangelos D Michelakis, Wayne Tymchak, Michelle Noga, et al.
Advances in Experimental Medicine and Biology|April 13, 2002
Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human modelsE D Michelakis, J R Dyck, M S McMurtry, et al.
Cell Metabolism|October 7, 2014
Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humansRoxane Paulin, Peter Dromparis, Gopinath Sutendra, et al.
Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.
Circulation|September 16, 2009
Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axisSébastien Bonnet, Roxane Paulin, Gopinath Sutendra, et al.
Circulation Research|June 26, 2004
Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cellsStephen L Archer, Xi-Chen Wu, Bernard Thébaud, et al.
Pageof 14